Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ETV3-NCOA2 in indeterminate cell histiocytosis: clonal translocation supports sui generis.

Literature DB >> 26438513

ETV3-NCOA2 in indeterminate cell histiocytosis: clonal translocation supports sui generis.

Ryanne A Brown¹, Bernice Y Kwong², Timothy H McCalmont³, Bruce Ragsdale⁴, Lisa Ma¹, Christine Cheung¹, Kerri E Rieger⁵, Daniel A Arber¹, Jinah Kim⁵.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2015 PMID： 26438513 DOI： 10.1182/blood-2015-07-655530

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes.

Authors: Lynn H Lee; Anjelika Gasilina; Jayeeta Roychoudhury; Jason Clark; Francis X McCormack; Joseph Pressey; Michael S Grimley; Robert Lorsbach; Siraj Ali; Mark Bailey; Philip Stephens; Jeffrey S Ross; Vincent A Miller; Nicolas N Nassar; Ashish R Kumar
Journal: JCI Insight Date: 2017-02-09

Review 2. Histiocytic neoplasms in the era of personalized genomic medicine.

Authors: Benjamin H Durham; Eli L Diamond; Omar Abdel-Wahab
Journal: Curr Opin Hematol Date: 2016-07 Impact factor: 3.284

Review 3. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Authors: Jean-François Emile; Oussama Abla; Sylvie Fraitag; Annacarin Horne; Julien Haroche; Jean Donadieu; Luis Requena-Caballero; Michael B Jordan; Omar Abdel-Wahab; Carl E Allen; Frédéric Charlotte; Eli L Diamond; R Maarten Egeler; Alain Fischer; Juana Gil Herrera; Jan-Inge Henter; Filip Janku; Miriam Merad; Jennifer Picarsic; Carlos Rodriguez-Galindo; Barret J Rollins; Abdellatif Tazi; Robert Vassallo; Lawrence M Weiss
Journal: Blood Date: 2016-03-10 Impact factor: 22.113

4. Special variant of histiocytosis.

Authors: Koen D Quint; Arjen H Cleven; Maarten H Vermeer
Journal: BMJ Case Rep Date: 2017-10-25

5. Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.

Authors: Fabio Facchetti; Stefano Aldo Pileri; Luisa Lorenzi; Valentina Tabanelli; Lisa Rimsza; Stefania Pittaluga; Stephan Dirnhofer; Christiane Copie-Bergman; Laurence de Leval; Andreas Rosenwald; Andrew Wotherspoon; Falko Fend
Journal: Virchows Arch Date: 2017-07-10 Impact factor: 4.064

ETV3-NCOA2 in indeterminate cell histiocytosis: clonal translocation supports sui generis.

1. Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes.

Review 2. Histiocytic neoplasms in the era of personalized genomic medicine.

Review 3. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

4. Special variant of histiocytosis.

5. Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.

Review 6. Diagnosis and classification of hematologic malignancies on the basis of genetics.

Review 7. Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology.

Review 8. Identification and Targeting of Kinase Alterations in Histiocytic Neoplasms.

Review 9. MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age.

10. Aggressive Indeterminate Dendritic Cell Tumor Mimicking Scalp Angiosarcoma.